Technology
Innovation that doesn’t disrupt anything but changes everything.
Technology that helps to create healthier nations.
Nightingale Health's technology has the transformative ability to simultaneously detect multiple disease risks for chronic diseases utilizing just a single blood sample. When adopted in healthcare, the technology replaces many routinely used disease risk detection tools with a more efficient and scalable approach while also saving healthcare professionals’ time. This efficiency translates to a more focused and preventative health system benefiting everyone. When the technology on applied in national scale, it provides a simple and effective roadmap towards improved national health.
Technology that turns the logic of blood testing better for everyone.
Over a century ago, the concept of blood testing was developed to analyze individual markers in the blood, aiming to identify the presence of specific diseases. While this method remains effective for diagnosing already manifested diseases, it inherently lacks the ability to thoroughly screen for the risk of multiple diseases in a holistic manner. Nightingale Health's technology introduces an improved approach to disease risk detection. It captures a wide array of blood markers from each sample and refines this data into a multi-disease risk assessment. This advanced risk assessment is conducted with every sample at every time point it is measured, providing a more effective and inclusive approach for everyone.
Groundbreaking combination of biotechnology and machine learning = the world’s most advanced disease risk detection.
Nightingale Health Check is the result of integrating several internally developed core technologies into one innovative tool. The first component involves Nightingale's proprietary high-throughput clinical laboratory method, which employs nuclear magnetic resonance (NMR) spectroscopy for measuring blood samples.
The second component consists of an in-house algorithm that utilizes advanced machine learning techniques to transform the spectral data obtained from the NMR method into a comprehensive set of blood markers commonly used in medical practice. These blood markers are integrated with the world's largest health outcome datasets that Nightingale has measured around the world. This integration enables the computation of disease risk models.
These core technologies power Nightingale Health Check — the most advanced risk detection tool in the world.
The only 'omic technology in large-scale clinical use.
Nightingale Health's technology has been built from the ground up for large-scale healthcare use. Over the past decade, Nightingale has differentiated its technology from many other 'omics technologies to enable its use in nationwide primary healthcare applications. This unique journey has made Nightingale Health's technology the only solution in the world that brings the benefits of a novel 'omic technology to large-scale clinical use. Our technology makes the advanced disease risk detection available for every measured blood sample while saving the time of healthcare professionals and reducing costs in health systems. This can be built on utilising existing skills of clinicians and other healthcare professionals – there is no need for extensive training. This is why Nightingale Health's technology is already adopted in nationwide healthcare.
World-leading scientific and clinical validation for preventative health applications.
Sustainable innovation in medicine relies on scientific scrutiny. Since its inception, Nightingale Health's technology has undergone thorough examination by leading medical scientists worldwide. Utilized by more than 200 medical research organizations in over 30 countries, the technology has been applied to over two million samples. Over 600 peer-reviewed publications attest to the effectiveness of Nightingale Health's technology. With this extensive dataset, there is no comparable technology globally with equivalent scientific and clinical evidence.